| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GEVO INC | 97,040 | 26,000 | 0.00% | Call | |
| 2 | Carbylan Therapeutics Inc. | 151,688 | 98,000 | 0.00% | ||
| 3 | RLJ ENTMT INC | 200,000 | 170,000 | 0.00% | Call | |
| 4 | BIND THERAPEUTICS INC | 114,786 | 253,000 | 0.00% | Call | |
| 5 | Nivalis Therapeutics Inc | 66,039 | 275,000 | 0.00% | ||
| 6 | VASCULAR BIOGENICS LTD | 83,333 | 290,000 | 0.00% | Call | |
| 7 | DISCOVERY LABORATORIES INC N | 178,570 | 298,000 | 0.00% | Call | |
| 8 | PARNELL PHARMACEUTICALS HOLDINGS LTD | 147,458 | 314,000 | 0.00% | ||
| 9 | BELLEROPHON THERAPEUTICS INC | 143,985 | 354,000 | 0.00% | ||
| 10 | UNIVERSAL INS HLDGS INC | 20,700 | 368,000 | 0.00% | ||
| 11 | TRANSITION THERAPEUTICS INC | 292,352 | 374,000 | 0.00% | ||
| 12 | CTI BIOPHARMA | 773,469 | 411,000 | 0.00% | ||
| 13 | VINCE HLDG CORP | 76,838 | 486,000 | 0.00% | ||
| 14 | BIOAMBER INC | 128,351 | 539,000 | 0.00% | Call | |
| 15 | BIOLINERX LTD | 599,530 | 612,000 | 0.01% | ||
| 16 | BURLINGTON STORES INC | 11,067 | 622,000 | 0.01% | ||
| 17 | VTV THERAPEUTICS INC | 128,646 | 664,000 | 0.01% | ||
| 18 | ANTARES PHARMA INC | 849,224 | 739,000 | 0.01% | ||
| 19 | DISCOVERY LABORATORIES INC N | 454,821 | 760,000 | 0.01% | ||
| 20 | MAST THERAPEUTICS INC COM | 2,969,381 | 810,000 | 0.01% | Call | |
| 21 | CERULEAN PHARMA INC | 312,809 | 848,000 | 0.01% | ||
| 22 | RELYPSA INC | 62,944 | 853,000 | 0.01% | ||
| 23 | Northstar Realty Fin REIT | 65,403 | 858,000 | 0.01% | ||
| 24 | AQUINOX PHARMACEUTICALS INC | 115,574 | 1,019,000 | 0.01% | ||
| 25 | ZAFGEN INC COM | 154,786 | 1,034,000 | 0.01% | ||
| 26 | RADWARE LTD | 93,203 | 1,103,000 | 0.01% | ||
| 27 | BARRACUDA NETWORKS INC | 72,251 | 1,113,000 | 0.01% | ||
| 28 | CONTINENTAL RESOURE | 39,177 | 1,189,000 | 0.01% | ||
| 29 | TURTLE BEACH CORP COM | 1,183,135 | 1,349,000 | 0.01% | ||
| 30 | GATX CORP | 29,306 | 1,392,000 | 0.01% | ||
| 31 | CATHAY GEN BANCORP | 50,308 | 1,425,000 | 0.01% | ||
| 32 | GENMARK DIAGNOSTICS INC. | 276,398 | 1,457,000 | 0.01% | ||
| 33 | FCB Financial Holdings Inc | 267,315 | 1,497,000 | 0.01% | ||
| 34 | ACCELERON PHARMA INC | 60,000 | 1,583,000 | 0.01% | ||
| 35 | GENOCEA BIOSCIENCES INC | 210,505 | 1,629,000 | 0.01% | ||
| 36 | IDERA PHARMACEUTICALS INCORPORATED COM NEW | 828,620 | 1,641,000 | 0.02% | ||
| 37 | SL GREEN RLTY CORP | 17,023 | 1,649,000 | 0.02% | ||
| 38 | BLUEPRINT MEDICINES CORP COM | 91,837 | 1,658,000 | 0.02% | ||
| 39 | GENERAL GROWTH | 56,169 | 1,670,000 | 0.02% | ||
| 40 | TOKAI PHARMACEUTICALS INC COM | 315,757 | 1,771,000 | 0.02% | ||
| 41 | INNOCOLL HLDGS PLC | 210,972 | 1,810,000 | 0.02% | ||
| 42 | MACQUARIE INFRASTRUCTURE COR | 27,024 | 1,822,000 | 0.02% | ||
| 43 | New Home Company Inc (The) | 150,000 | 1,839,000 | 0.02% | ||
| 44 | VIRTUS INVT PARTNERS INC COM | 23,547 | 1,839,000 | 0.02% | ||
| 45 | DEPHEID | 57,297 | 1,911,000 | 0.02% | ||
| 46 | Life Technologies Corp | 490,750 | 1,934,000 | 0.02% | ||
| 47 | NEVRO CORP COM | 34,617 | 1,948,000 | 0.02% | ||
| 48 | KILROY RLTY CORP COM | 31,533 | 1,951,000 | 0.02% | ||
| 49 | BROADSOFT INC | 48,653 | 1,963,000 | 0.02% | ||
| 50 | UDR INC | 50,989 | 1,965,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-16-000263, filed 2016.05.16), New Holdings filing (0001164691-17-000147, filed 2017.08.17), New Holdings filing (0001453072-17-000029, filed 2017.02.17), New Holdings filing (0001164691-16-000326, filed 2016.11.18). and New Holdings filing (0001164691-16-000299, filed 2016.08.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
